Atlas Trials

Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability

Clinical trial NCT05853198 · UNKNOWN

Trial details

NCT number
NCT05853198
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
PDAC - Pancreatic Ductal Adenocarcinoma
Start date
2022-12-29
Primary completion
2026-05-31
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.